{
  "title": "Nobel Laureate Economist on Vaccine Equity",
  "itunes:title": "Nobel Laureate Economist on Vaccine Equity",
  "description": "<p>Dr. Seth Lederman, CEO at Tonix Pharmaceuticals, discusses continuing clinical trials for Covid vaccines. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Economy Reporter Olivia Rockeman talks about the unemployment system being plagued by $63 billion in fraud and dysfunction. Nobel Laureate Economist and Columbia University Professor Joseph Stiglitz shares his insight on vaccine equity, debt relief, and fiscal capacity in the developing world. And we Drive to the Close with Kathy Boyle, President at Chapin Hill Advisors.</p><p>Hosts: Carol Massar and Tim Stenovec. Producer: Doni Holloway.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Dr. Seth Lederman, CEO at Tonix Pharmaceuticals, discusses continuing clinical trials for Covid vaccines. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Economy Reporter Olivia Rockeman talks about the unemployment system being plagued by $63 billion in fraud and dysfunction. Nobel Laureate Economist and Columbia University Professor Joseph Stiglitz shares his insight on vaccine equity, debt relief, and fiscal capacity in the developing world. And we Drive to the Close with Kathy Boyle, President at Chapin Hill Advisors.</p><p>Hosts: Carol Massar and Tim Stenovec. Producer: Doni Holloway.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "84e525fe-8c1b-11eb-af99-533c4328b1f3",
  "omny:clipId": "b1e18ff8-9872-4f00-ba35-ae2b003ef9de",
  "pubDate": "Tue, 23 Mar 2021 21:18:09 +0000",
  "itunes:duration": 2414,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/nobel-laureate-economist-on-vaccine-equity"
}